article · The Journal of Maternal-Fetal & Neonatal Medicine
BACKGROUND: The use of antiretroviral therapy (ART) during pregnancy among women living with human immunodeficiency virus (HIV) may adversely affect their cardiometabolic health, but its influence on fetal growth remains underexplored. This study aimed to investigate the relationship between maternal cardiometabolic health and fetal growth in pregnant women living with HIV receiving ART in Mthatha, South Africa. METHODS: ≤ 0.05. RESULTS: ≤ 0.05) was found between maternal UtA PI and fetal growth parameters such as AC, FL and HC. CONCLUSION: Vascular dysfunction was observed in pregnant women living with HIV on ART coupled with an inverse association between maternal vascular function and fetal growth suggesting that impaired maternal vascular function may limit placental blood flow and potentially affect fetal growth.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/14767058.2026.2674269
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.